BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6302487)

  • 1. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new type of transmitter release at the neuromuscular junction.
    Thesleff S; Molgó J
    Neuroscience; 1983 May; 9(1):1-8. PubMed ID: 6308500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-insensitive miniature endplate potentials at the neuromuscular junction.
    Lupa MT
    Synapse; 1987; 1(4):281-92. PubMed ID: 2843994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmitter release in botulinum-poisoned muscles.
    Thesleff S
    J Physiol (Paris); 1984; 79(4):192-5. PubMed ID: 6152289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the calcium-insensitive, intermittent acetylcholine release at the rat neuromuscular junction.
    Tabti N; Lupa MT; Yu SP; Thesleff S
    Acta Physiol Scand; 1986 Nov; 128(3):429-36. PubMed ID: 3788620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S; Molgó J; Lundh H
    Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three types of transmitter release from embryonic neurons.
    Poo MM; Sun YA; Young SH
    J Physiol (Paris); 1985; 80(4):283-9. PubMed ID: 3009797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tetrandrine on spontaneous and evoked release of acetylcholine at the mouse neuromuscular junction.
    Wiegand H; McIntosh LJ; Gotzsch U; Krämer U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):891-901. PubMed ID: 8930197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction.
    Atchison WD
    J Pharmacol Exp Ther; 1986 May; 237(2):672-80. PubMed ID: 3084765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miniature endplate potentials induced by ammonium chloride, hypertonic shock, and botulinum toxin.
    Vautrin J
    J Neurosci Res; 1992 Feb; 31(2):318-26. PubMed ID: 1573682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for the dynamic formation of transmitter quanta at the neuromuscular junction.
    Vautrin J; Kriebel ME; Holsapple J
    J Neurosci Res; 1992 Jun; 32(2):245-54. PubMed ID: 1357188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG; Lambert EH; Gomez MR
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant miniature endplate potentials induced by 4-aminoquinoline.
    Molgó J; Gomez S; Polak RL; Thesleff S
    Acta Physiol Scand; 1982 Jun; 115(2):201-7. PubMed ID: 7136813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.